Search
for
Sort by
Research 30 of 1000+
- Generic Development of Topical Dermatologic Products: Formulation Development, Process Development, and Testing of Topical Dermatologic Products
- Australian Medicines Handbook 2003
- Prescription Pattern in Dermatological Conditions of the Pediatric Population
- A guide to cost-effective emollient prescribing
- Diseases of Hair and Nails
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- The PDGF/PDGFR pathway as a drug target
- Natural products and their derivatives as candidate treatments for hair greying: from drug discovery to molecular mechanisms
- Improving the efficacy of anti-hair loss drugs treatments with a cosmetic lotion containing caffeine, taurine and growth factors
- Retrospective analysis of smell and taste disturbances associated with dermatologic medications reported to the United States Food and Drug Administration and relevance to COVID-19 infections
- Chemically Induced Hair Loss/Alopecia
- Formulation Development and In-Vitro Evaluation of Glycerosomes Containing Mionoxidil for Topical Application
- Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment
- The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil
- Tamsulosin versus finasteride: effect on bother and urinary flow
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases
- Long‐term safety and efficacy of bimatoprost solution 0·03% application to the eyelid margin for the treatment of idiopathic and chemotherapy‐induced eyelash hypotrichosis: a randomized controlled trial
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- A serious side effect of a potentially widely used cosmetic product
- Anaesthetics and platelets.
- Duration of finasteride and dutasteride treatment linked to long-term erectile dysfunction
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- 5α-Reductase underscores the development of pectoral fin breeding tubercles in zebrafish
- Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Cutaneous drug reactions
- Microneedles as the technique of drug delivery enhancement in diverse organs and tissues
- Absorption sites of orally administered drugs in the small intestine